Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Missouri tracks PSE sales

This article was originally published in The Tan Sheet

Executive Summary

Missouri becomes the fourth state to track sales of OTC pseudoephedrine-containing medicines with the National Precursor Log Exchange, the Consumer Healthcare Products Association announces March 8. NPLEx is a real-time, statewide electronic log that helps block illegal sales of PSE, a precursor used to create methamphetamine. CHPA offers the system to states for free as an alternative to moving PSE products to Rx only. So far only Colorado and Mississippi switched OTC PSE drugs to Rx to curb illegal sales and meth production (1"The Tan Sheet" Feb. 8, 2010).... Washington Senate votes to track PSE sales: The Washington state Senate passes a bill March 12 directing the state Board of Pharmacy to establish an electronic tracking system for PSE, ephedrine and phenylpropanolamine products by next July. The bill also raises the daily sales limit for drugs containing meth precursors to 3.6 grams to match the federal limit. Previously, the bill capped the daily total at 3 grams or a single package of any product with the ingredients. A similar bill passed the state house previously
Advertisement

Related Content

Topics

Advertisement
UsernamePublicRestriction

Register

PS103895

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel